2-hexadecanoylamino-4-nitrophenylphosphorylcholine: sphingomyelin analog cleaved by sphingomyelinase used for detection of homozygotes and heterozygous carriers of Niemann-Pick disease; structure
ID Source | ID |
---|---|
PubMed CID | 173737 |
SCHEMBL ID | 11662681 |
MeSH ID | M0056477 |
Synonym |
---|
2-hexadecanoylamino-4-nitrophenylphosphorylcholine |
FT-0669159 |
hdanppcholine |
(2-((hydroxy(4-nitro-2-(palmitoylamino)phenoxy)phosphinyl)oxy)ethyl)trimethylammonium hydroxide |
einecs 262-234-1 |
2-((hydroxy(4-nitro-2-((1-oxohexadecyl)amino)phenoxy)phosphinyl)oxy)-n,n,n-trimethylethanaminium, hydroxide |
2-hexadecanoylamino-4-nitrophenylphosphocholine |
2-n-(hexadecanoyl)-amino-4-nitrophenylphosphorylcholine |
60438-73-5 |
hnp cpd |
2-(n-hexadecanoylamino)-4-nitrophenylphosphocholine hydroxide |
2-n-hexadecanoylamino-4-nitrophenylphosphorylcholine |
SCHEMBL11662681 |
DTXSID90209181 |
[2-[[hydroxy[4-nitro-2-(palmitoylamino)phenoxy]phosphinyl]oxy]ethyl]trimethylammonium hydroxide |
2-[[2-(hexadecanoylamino)-4-nitrophenoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium;hydroxide |
hda-pc |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (70.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.60) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |